DDX39 Is Down-regulated in Chromophobe Renal Cell Carcinoma Tissues, Whereas Overexpression Is Associated With...

Renal cell carcinoma (RCC) accounts for 85% of kidney tumors, and its incidence is rising. It includes 14 histological subtypes, notably clear cell (KIRC), papillary (KIRP), and chromophobe (KICH) RCC. While RCC generally has a favorable prognosis, the 5-year survival rate drops to ~12% with distant metastasis. Identifying prognostic markers is therefore crucial. DDX39, a DEAD-box RNA helicase, is up-regulated in various cancers, but its prognostic role in KIRP and KICH remains unclear. This study investigates the clinical relevance of DDX39 expression in KIRC, KIRP, and KICH using TCGA bioinformatics data.

The University of ALabama at Birmingham CANcer data analysis Portal (UALCAN) platform was used to analyze DDX39 mRNA expression and survival in patients with KIRC, KIRP and KICH from The Cancer Genome Atlas (TCGA) database.

DDX39 mRNA levels were found to be significantly higher in KIRC and KIRP tissues compared to normal kidney tissues, and this up-regulation was inversely correlated with prolonged survival in KIRC and KIRP patients. However, DDX39 mRNA levels in KICH tissues were significantly lower than those in normal kidney tissues. Nevertheless, patients with high DDX39 mRNA expression in KICH tissues had significantly shorter survival times.

Although the expression levels of DDX39 mRNA in tumor tissues varies depending on the tissue type, expression is inversely correlated with patient prognosis, making it a promising prognostic factor in RCC, including KICH.